A Multicenter, Patient-Masked, Safety Extension Study to Evaluate the Biodegradation of the Brimonidine Tartrate Posterior Segment Drug Delivery System

Update Il y a 4 ans
Reference: EUCTR2010-019079-32

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To evaluate the biodegradation and related safety profile of the intravitreal Brimonidine Tartrate Posterior Segment Drug Delivery System (Brimo PS DDS®) Implant


Inclusion criteria

  • Patients who participated in a previous intravitreal Brimo PS DDS study, including 190342-031D (Rhegmatogenous Macula-off Retinal Detachment)